Header Logo

Connection

Michael Kiernan to Spironolactone

This is a "connection" page, showing publications Michael Kiernan has written about Spironolactone.
Connection Strength

0.637
  1. Kiernan MS, Konstam MA. Moderate renal insufficiency does not attenuate the clinical benefit of aldosterone antagonists in heart failure. J Am Coll Cardiol. 2012 Nov 13; 60(20):2090-1.
    View in: PubMed
    Score: 0.408
  2. Natov PS, Ivey-Miranda JB, Cox ZL, Rao VS, Butler J, Konstam MA, Kiernan MS, Kapur NK, Testani JM. Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does not Enhance Decongestion. J Card Fail. 2024 Nov; 30(11):1522-1526.
    View in: PubMed
    Score: 0.230
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.